force_id,pt_report,xgb_report,psu_occlusion,pt_psu_gt,gpt_0shot_response,human_assessment0,yesno_gt
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided patient data, I would predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications. This inference is supported by the absence of any documented history of neurological issues such as stroke, transient ischemic attacks, or cardiac events that could jeopardize brain health. Moreover, the absence of other significant complications typically associated with seizures (like notable cardiac arrhythmias or hematological issues) strengthens the likelihood that the patient has maintained neurological stability post-surgery. Thus, given the comprehensive negative history regarding seizures and associated risk factors, the predicted outcome is negative for seizures requiring treatment.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, I predict that the patient does **not** have a history of pacemaker placement. This prediction is supported by the absence of any documented history of atrial tachyarrhythmias or sustained ventricular arrhythmias, which are common indications for pacemaker placement in single-ventricle patients, especially post-Fontan. Moreover, the patient's current NYHA class is deemed satisfactory, suggesting that their cardiac function is stable and may not require additional pacing support at this time. The lack of arrhythmia history and ongoing management with anticoagulants and diuretics further implies that there haven’t been major rhythm control issues that would necessitate a pacemaker.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, I would predict that the patient has not died (no). The patient has no reported significant complications such as thrombus, stroke, or heart transplant—which are often associated with worse outcomes in single-ventricle patients post-Fontan surgery. Additionally, the patient is currently on anticoagulants and diuretics, which suggests ongoing management of cardiovascular health, potentially contributing to a stable condition. Furthermore, there is no indication of severe heart failure (suggested by NYHA class being noted as ""yes"") or critical interventions post-surgery that might indicate imminent mortality.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I predict that the patient does not have a history of ascites (> trace). This is supported by the absence of key indicators of complications commonly associated with ascites, such as a positive fibrosure or elevated liver fibrosis tests, which could suggest liver dysfunction that might lead to fluid accumulation. Additionally, the absence of other significant complications—such as symptoms of protein-losing enteropathy, cardiac arrest, or major thrombus—indicates a relatively stable clinical status post-Fontan. The patient’s current treatment regimen does involve diuretics, which can manage fluid retention but does not inherently indicate the presence of ascites, further supporting the conclusion.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, I predict that the patient did not receive a heart transplant (no). The patient has no reported serious complications commonly associated with Fontan failure or subsequent transplant needs, such as significant arrhythmias, renal dysfunction, or issues with liver function (e.g., ascites, hepatocellular carcinoma). Additionally, the patient is currently on diuretics and anticoagulant therapy, which suggests careful management of their condition without an immediate indication for transplantation. The absence of severe health complications or chronic issues increases the likelihood that the patient has been maintained adequately following the Fontan surgery, thus reducing the need for a heart transplant.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided patient data, it is highly likely that the patient does not have a history of ascites (> trace). The absence of diagnoses such as protein-losing enteropathy, hepatocellular carcinoma, and significant liver dysfunction is notable. Furthermore, the patient has not experienced any known complications related to fluid retention, such as chylous pleural effusions or significant pleural effusions post-Fontan surgery. Given the overall stable clinical status, including no significant cardiac or renal complications, it is reasonable to conclude that ascites is not present in this patient.",1,0
BCH-BEABEN-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, the prediction for the missing clinical outcome, ""Has the patient died?"" is **no**. The patient has a complex medical history, including an intracardiac thrombus and atrial tachyarrhythmias, which are serious conditions but do not necessarily indicate an imminent risk of death if managed properly. Additionally, the absence of significant adverse outcomes, such as stroke or heart failure symptoms indicated by the NYHA class, suggests that the patient's current condition is stable. Furthermore, the patient's history of regular medical management with anticoagulants and diuretics indicates active monitoring and treatment, which contribute to improved survival rates in single-ventricle patients post-Fontan surgery.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, it is likely that the patient did not receive a heart transplant (no). The presence of an intracardiac thrombus, along with a history of atrial tachyarrhythmias, suggests significant ongoing cardiac complications that could complicate clinical management but do not necessarily equate to transplant necessity at this point. Additionally, the fact that the patient is still alive and has no acute indications for transplantation—such as severe heart failure symptoms or diminished functional capacity indicated by the NYHA classification—further supports this prediction. The absence of adjunct factors like sustained arrhythmias or other significant morbidity would indicate that while the patient's heart condition requires monitoring and management, it has not yet reached the threshold for transplant consideration.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I would predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications. The absence of any reported history of stroke, transient ischemic attacks, or peri-operative complications suggests a lower likelihood of neurological issues, including seizures. Additionally, while the patient has a history of intracardiac thrombus and atrial tachyarrhythmias, there is no evidence of related neurological sequelae that could lead to seizure activity, such as a history of cerebrovascular accidents. Therefore, the patient's clinical picture does not support the presence of seizure disorders requiring treatment.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, it is reasonable to predict that the patient does **not** have a history of pacemaker placement (no). The patient has demonstrated an occurrence of atrial tachyarrhythmias, which may sometimes necessitate pacing interventions; however, there is no recorded history of defibrillator use or sustained ventricular arrhythmias that would typically prompt pacemaker placement. Additionally, the absence of significant interventions such as ECG studies related to arrhythmias and the non-reporting of symptoms or interventions that commonly arise from arrhythmias suggest a more stable cardiac rhythm that does not require a pacemaker. Thus, these factors indicate an ability to manage their rhythm without the need for permanent pacing.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, it is predicted that the patient has **not died**. The patient has no reported history of severe complications typically associated with higher mortality risk, such as protein-losing enteropathy, significant arrhythmias, or thromboembolic events. Additionally, the patient's current status indicates they are under various medications, including anticoagulants and a pacemaker, suggesting ongoing monitoring and management, which is consistent with survival. The absence of critical postoperative complications and the proactive treatment measures imply stability and a better prognosis for the patient.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information about the main patient, it can be predicted that the patient did not receive a heart transplant (no). The absence of significant complications such as significant thrombus history, arrhythmias requiring extensive management, or advanced heart failure indicators (such as the need for mechanical support or ECMO) suggests that the patient has managed their condition relatively well post-Fontan. Additionally, the fact that they are on anticoagulant therapy and have a pacemaker indicates close monitoring and management, which may imply stability rather than deterioration typically leading to transplant evaluation. The patient's current NYHA status also suggests that they may not be in end-stage heart failure, which would decrease the likelihood of having undergone transplantation.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"**Prediction:** No, the patient does not have a history of ascites (> trace).

**Reasoning:** The patient's MRI report and surgical history suggest a relatively stable clinical condition, with no indications of significant complications typically associated with the development of ascites. Notably, the patient has no history of protein-losing enteropathy, hepatic issues, or renal dysfunction, all of which can contribute to fluid retention and ascites. Furthermore, the absence of any significant cardiac events or interventions that might compromise liver function or cardiovascular status further supports the prediction of no ascites.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I would predict that the main patient does **not** have a diagnosis of seizures requiring antiepileptic medications. The absence of significant neurological complications such as stroke or transient ischemic attack, along with the patient’s stable cardiac status evidenced by no history of arrhythmias or cardiac arrest, suggests a reduced risk for seizure activity. Furthermore, the patient does not appear to be on any medications typically used for seizure management, such as antiepileptic drugs. The overall picture indicates a stable neurological and cardiovascular condition, making the likelihood of seizures low.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided data, I predict that the patient does **not** have a history of pacemaker placement. The patient's MRI report indicates that they had a post-Fontan electrophysiologic study, which may suggest an evaluation for arrhythmias; however, there is no mention of any history of arrhythmias or related complications that often lead to pacemaker placement. Additionally, the absence of a history of atrial tachyarrhythmias or sinus node dysfunction further supports the conclusion that the patient likely has maintained stable cardiac function, reducing the need for pacing interventions at this time. Therefore, it is reasonable to infer that the patient has likely not required a pacemaker.",0,1
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I would predict that the patient does **not** have a history of ascites (> trace). The patient shows no signs of significant clinical complications commonly associated with Fontan physiology, such as protein-losing enteropathy, which can often lead to the development of ascites due to fluid retention and hypoalbuminemia. Additionally, the absence of pleural effusions or renal dysfunction further suggests effective fluid management and cardiac function. The presence of atrial tachyarrhythmias and sinus node dysfunction indicates some level of cardiovascular compromise, but the overall absence of major complications and normal anticoagulation medication suggests that ascites are unlikely to be a significant issue for this patient.",1,0
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, the most likely prediction for whether the patient has a diagnosis of seizures requiring antiepileptic medications is **no**. The patient's history indicates the presence of atrial tachyarrhythmias and sinus node dysfunction, which typically suggest a risk of arrhythmias rather than neurological issues like seizures. Additionally, there is no recorded history of stroke or transient ischemic attacks, which are commonly associated with seizure disorders. Consequently, the absence of these factors strengthens the rationale that seizures are not a clinical outcome for this patient.",1,0
BCH-CASKEV-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, the prediction is that the patient has not died (""no""). The patient's MRI report and surgical history indicate a lack of significant complications commonly associated with high mortality risks in single-ventricle patients, such as major thrombus, stroke (peri-operative or non-peri-operative), severe arrhythmias, or requiring ECMO. While there is a history of atrial tachyarrhythmias and sinus node dysfunction that necessitated pacemaker placement, these issues are often manageable with proper follow-up care, suggesting the patient remains stable. Additionally, the patient is currently on anticoagulants and beta blockers, indicating active management of potential cardiovascular issues, which likely contributes to better outcomes.",1,0
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, I predict that the patient did not receive a heart transplant (no). The patient has a history of atrial tachyarrhythmias and sinus node dysfunction, but there is no documentation of significant complications that typically precede a transplant, such as severe heart failure symptoms (reflected in the NYHA class) or end-stage heart disease. The absence of major adverse events, such as pulmonary or renal dysfunction, and the current use of medications such as anticoagulants and beta blockers suggests that their cardiac condition is being managed without the need for transplantation at this time. Moreover, the patient’s 'Current NYHA class' status indicates some degree of functional capacity, implying they have not reached a stage warranting transplant consideration.",1,0
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided clinical data, I would predict that the patient does not have a history of pacemaker placement (no). This conclusion stems from the patient's documented conditions and medications. The patient has a history of atrial tachyarrhythmias and sinus node dysfunction, which can often necessitate rhythm management strategies such as a pacemaker; however, there is no evidence of sustained ventricular arrhythmias, defibrillator use, or the need for post-Fontan electrophysiologic interventions, which may indicate a lesser degree of arrhythmic burden. Additionally, the patient is managed on medication like beta-blockers and anticoagulants, suggesting that if significant arrhythmias were present, a more invasive approach such as pacemaker placement might have been considered.",1,1
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? yes
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, it is unlikely that the patient received a heart transplant. The patient had a significant history of arrhythmias and was diagnosed with severe complications, including presumed cardiac arrest due to malignant arrhythmia shortly before their death. Given the advanced nature of these complications and the presence of an intracardiac thrombus, it is probable that the patient's condition deteriorated to a point where transplant candidacy was not feasible or pursued. Furthermore, the report indicates a lack of intervention such as a post-Fontan electrophysiologic study or pacemaker placement, which could imply that the patient's cardiac status was too compromised during their last follow-up.",1,0
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,"[' Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure\r\nShe was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""\n Has the patient died? yes\n If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest\n']","Based on the provided information, it is reasonable to predict that the patient has not died (no). Although the patient has a significant medical history, including intracardiac thrombus, stroke, and atrial tachyarrhythmias, there are no reports of recent life-threatening events or conditions that suggest imminent mortality, such as sustained ventricular arrhythmias or active major organ dysfunction. Furthermore, the absence of advanced interventions like ECMO or heart transplantation implies that the patient's condition is being managed without acute life-threatening crises. These factors collectively suggest that while the patient has complex health challenges, they have not yet resulted in death.",1,1
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? yes\n'],"Based on the provided data, I would predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). While the patient has a complex cardiac history, including atrial and ventricular arrhythmias and a history of intracardiac thrombus, there is no documentation of neurological symptoms or a history of seizure activity in the provided records. Additionally, the acute event leading to the patient's death was attributed to arrhythmia rather than any neurological event, suggesting that seizures have not been a significant concern during her management. Thus, the absence of these conditions in her history indicates that seizures are unlikely in this case.",1,1
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I would predict that the patient does **not** have a history of ascites (> trace). The key indicators supporting this prediction are the patient's symptoms and treatments; while she experienced significant respiratory distress and pedal edema, which are associated with fluid retention, there is no indication of abdominal swelling or ascites in the report. Additionally, she has no history of protein-losing enteropathy or chylous effusions, which are often linked with ascites development in post-Fontan patients. The combination of these factors suggests that ascites was likely not a significant issue for this patient.",1,0
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the information provided, it can be reasonably predicted that the patient does **not** have a history of pacemaker placement (no). The patient has a significant history of arrhythmias, including atrial tachyarrhythmias and non-sustained ventricular tachyarrhythmias, but there is no mention of sustained ventricular arrhythmias, sinus node dysfunction, or incidents that would typically necessitate a pacemaker, such as symptomatic bradycardia or recurrent arrhythmogenic events requiring pacing support. Moreover, other clinical interventions such as defibrillator use or a history of elective cardioversion were also absent, which further supports the likelihood that a pacemaker was not indicated at any point in the patient’s care.",1,0
BCH-COBJAM-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the patient data provided, it is reasonable to predict that the patient has not died (no). The patient has a history of stroke (peri-operative), but there are no indications of severe complications such as cardiac arrest, significant arrhythmias, or organ dysfunction (e.g., renal or hepatic issues). Furthermore, the patient is on anticoagulant therapy, which suggests ongoing management of thrombotic risks, and currently holds a NYHA class designation, indicating stable heart function. The absence of other fatal conditions, such as protein-losing enteropathy or major thrombus, further supports the likelihood of survival.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, it is reasonable to predict that the patient does not have a history of ascites (> trace) (no). This conclusion is supported by the absence of any other significant chronic complications typically associated with Fontan physiology that could lead to fluid overload, such as a history of protein-losing enteropathy or renal dysfunction, both of which can contribute to ascitic fluid accumulation. Additionally, the patient's current NYHA class is not mentioned as poor, and there’s no mention of ongoing diuretic therapy, which often indicates management of volume status related to fluid retention conditions like ascites. Therefore, the collected evidence suggests a lower likelihood of the patient experiencing this complication.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the information provided, the prediction for whether the patient has a history of pacemaker placement is ""no."" The patient exhibits no significant history of arrhythmias, which are common indicators for pacemaker placement, and there is no mention of sustained ventricular tachyarrhythmias or the need for emergent cardioversion—both of which might suggest a risk for rhythm disturbances that would warrant such a device. Moreover, the patient's current NYHA class and the use of anticoagulants, ACE inhibitors, and specific medications for heart failure management do not correlate with a prior need for pacing support. Thus, the absence of these risk factors leads to the conclusion that it is unlikely the patient has received a pacemaker.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, it is reasonable to predict that the patient did not receive a heart transplant (no). The patient has a history of a stroke but no other significant complications like protein-losing enteropathy, major thrombus, or significant arrhythmias that often necessitate transplant considerations in single-ventricle patients. Additionally, the patient is currently on anticoagulants and an ACE-I/ARB, which indicates a managed cardiac status rather than critical decline. Their NYHA status suggests some level of functional capacity, further supporting the likelihood of avoiding transplantation at this time.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, it is predicted that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient's medical history indicates a past stroke occurrence (peri-operative) which could suggest a risk for neurological complications, but there are no recorded instances of seizures or related transient episodes. Additionally, the patient has no previous diagnoses of other conditions typically associated with seizures, such as non-traumatic brain injury or structural brain anomalies typically highlighted in MRI reports. Overall, the absence of these factors strongly supports the prediction that seizures are unlikely.",1,0
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided data, I predict that the patient has a **history of ascites (> trace): no**. The patient's MRI report highlights significant issues such as a history of pleural effusions, previously mentioned as non-chylous occurring greater than 30 days post-surgery, indicating fluid accumulation but not specifically in the abdominal cavity. Additionally, the patient's history of elevated liver fibrosis could suggest some level of hepatic dysfunction, which is often associated with ascites; however, the absence of other associated symptoms, such as protein-losing enteropathy or significant hepatic issues leading to fluid accumulation, leads to the conclusion that ascites is not present in this patient.",0,1
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided patient data, it is reasonable to predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient's history indicates several complications common in single-ventricle patients post-Fontan, such as pleural effusions, renal dysfunction, and arrhythmias, but there is no explicit mention of seizure activity or treatment for seizures. Additionally, the absence of prior strokes and transient ischemic attacks suggests a lower likelihood of neurological complications like seizures. Overall, the data does not support the presence of a seizure disorder.",1,0
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided patient data, I predict that the patient does **not** have a history of pacemaker placement (no). The patient has a history of atrial tachyarrhythmias but no documentation of sustained ventricular arrhythmias or defibrillator placement, which suggests that their arrhythmias may be managed without the need for a pacemaker intervention. Additionally, the patient's numerous medications—including beta blockers and antiarrhythmics—indicate a management strategy focusing on medical treatment rather than device-dependent therapy. Lastly, the absence of signs related to significant conduction issues or prior electrophysiologic studies further supports the conclusion that a pacemaker was likely not required for this patient.",1,1
BCH-COFRAC-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, it is likely that the patient has not died. The main patient does not have a history of significant adverse events such as stroke, cardiac arrest, or major thrombus formation, which are common precursors to mortality in single-ventricle patients post-Fontan surgery. Additionally, while the patient has some concerning issues like elevated liver fibrosis and renal dysfunction, they are under treatment with multiple cardiac medications and anticoagulants, which suggests ongoing management of their health status. The absence of severe arrhythmic events and the lack of a history indicating critical deterioration further support the likelihood of survival at this point in time.",1,0
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided clinical information about the patient, it seems likely that they did not receive a heart transplant. The patient exhibits several concerning factors such as a history of renal dysfunction, elevated liver fibrosis tests, and chylous pleural effusions, which are often associated with significant morbidity in Fontan patients. These complications, along with the need for medications like diuretics and beta-blockers, suggest that the patient's condition is complex but stable enough to manage without a transplant. Furthermore, the absence of significant arrhythmias such as ventricular tachycardia or ventricular fibrillation indicates that the cardiac function may be relatively preserved, reducing the immediate necessity for transplant intervention.",1,0
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided data, it is predicted that the patient does **have a history of pacemaker placement**. This conclusion stems from the patient's documented history of atrial tachyarrhythmias and sinus node dysfunction, which are conditions commonly associated with the need for pacing support. Additionally, the use of beta blockers and the history of non-sustained ventricular tachyarrhythmias may suggest previous attempts to manage arrhythmias, potentially leading to the decision to implant a pacemaker. The patient’s overall cardiac status, including the positive fibrosure indicating liver complications and renal dysfunction, may have contributed to the complexity of managing their arrhythmias, further supporting the likelihood of a pacemaker being necessary.",1,1
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided data, I would predict that the patient **does not have a history of ascites**. The patient shows significant complications related to their cardiac condition, including renal dysfunction, a positive fibrosure indicating potential liver issues, and a history of hemoptysis; however, there is no direct indication of ascites, which often arises from severe liver dysfunction or heart failure. The absence of any documented pleural effusions, particularly non-chylous effusions, and the lack of clinical management commonly associated with ascites, like dietary modifications or paracentesis, further supports the absence of this condition. Moreover, the patient's management with diuretics might indicate some volume issues, but it does not directly lead to a conclusion of ascites without higher indicators of fluid accumulation.",0,1
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data, it is reasonable to predict that the patient did not receive a heart transplant (no). The patient exhibits signs of multiple complications typically associated with impaired cardiac function (such as renal dysfunction, liver fibrosis, and evidence of arrhythmias), but there is no direct indication of end-stage heart failure or crippling symptoms that would necessitate a transplant. Furthermore, the fact that the patient has a history of cardiac arrhythmias, a pacemaker in place, and is currently on diuretics suggests ongoing management of heart function without the need for transplantation at this time. Therefore, given the clinical scenario and existing complications, heart transplantation may not have been deemed necessary, leading to the prediction of ""no"" for this outcome.",1,0
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the patient's history of non-peri-operative stroke and the presence of various cardiac arrhythmias, it is reasonable to predict that the patient would likely have a diagnosis of seizures requiring antiepileptic medications (yes). The history of stroke increases the risk of neurological sequelae, including seizures. Additionally, the indication of cerebral vascular issues, alongside renal dysfunction and other significant health complications, suggests a likelihood of neurological instability that could manifest as seizures. Moreover, the presence of a diagnosis of transient ischemic attacks could further contribute to the patient's potential for seizures, reinforcing the need for antiepileptic treatment.",0,0
BCH-DACKEL-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, it is possible to predict that the patient has not died (no). While the patient exhibits several concerning health issues, including a history of non-perioperative stroke, renal dysfunction, and significant liver fibrosis, these conditions alone do not necessarily indicate imminent mortality. Furthermore, the patient continues to receive active medical management, including the use of anticoagulants, diuretics, and beta blockers, which suggests ongoing care and monitoring. The lack of recent fatal complications, such as cardiac arrest or sustained ventricular tachycardia, further supports the inference that the patient is currently alive.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, I predict that the patient did not receive a heart transplant (no). The patient has several concerning factors, including a history of intracardiac thrombus and atrial tachyarrhythmias, suggesting potential complications related to cardiac function but not necessarily leading to transplant criteria being met at this stage. Moreover, the absence of diagnoses such as protein-losing enteropathy and the maintenance of non-sustained ventricular tachyarrhythmias imply some level of stability in cardiac function. The patient’s current NYHA classification status is also indicative of a relatively stable condition, which further supports the likelihood of not requiring transplantation.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the patient's medical history, there are indications of significant cardiac issues, including a history of atrial tachyarrhythmias, which often is a reason for pacemaker placement in patients with single-ventricle physiology post-Fontan surgery. Additionally, the presence of an intracardiac thrombus and the ongoing anticoagulation and beta-blocker medications may suggest management of arrhythmias or risk related to thromboembolic events, which could further support the need for a pacemaker. However, since there is no reported history of defibrillator placement or interventions solely focused on rhythm stabilization, it is more plausible that the patient does not have a pacemaker. Therefore, I predict that the patient does **not** have a history of pacemaker placement.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I predict that the patient **does not have a history of ascites (> trace)**. Despite the presence of significant cardiovascular issues such as intracardiac thrombus and atrial tachyarrhythmias, the patient shows no indications of associated complications commonly linked to heart failure, such as pleural effusions or liver dysfunction which can lead to ascites. The absence of mentions regarding liver fibrosis tests, renal dysfunction, and notable symptoms like chylous pleural effusions suggests that cirrhosis or significant fluid retention has been avoided, making it less likely for the patient to develop ascites.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, it is reasonable to predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient has no documented history of strokes, transient ischemic attacks, or cardiac arrest, all of which can predispose individuals to seizures. Additionally, the presence of atrial tachyarrhythmias may suggest some cardiac instability, but there is no indication of neurologic events that typically correlate with seizure activity. Therefore, with the absence of such significant neurological events and no evidence of ongoing seizure activity or related treatment, it is logical to conclude that the patient is not diagnosed with seizures requiring medication.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, I predict that the patient has not died. The absence of notable risk factors, such as a history of cardiac arrest or acute major complications like extracorporeal membrane oxygenation (ECMO) usage, suggests a relatively stable condition. Additionally, while the patient does have a history of atrial tachyarrhythmias and an intracardiac thrombus, there are no indications of severe complications stemming from these issues, as the patient has not experienced non-perioperative strokes or significant heart dysfunction. Furthermore, the patient is on multiple medications to manage atrial dysrhythmias and optimize cardiac function, which indicates ongoing monitoring and management that would likely reduce mortality risk.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I would predict that the missing clinical outcome is ""no,"" the patient does not have a diagnosis of seizures requiring antiepileptic medications. The patient has a comprehensive history free from neurologic complications, as evidenced by the absence of any stroke, transient ischemic attack, or cardiac arrest episodes, which often correlate with seizure activity in this patient population. Furthermore, there are no reported instances of anesthesia-related complications or other symptoms typically associated with seizure disorders. Given these factors, it seems unlikely that the patient has seizures requiring treatment with antiepileptic medications.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, it is likely that the patient did not receive a heart transplant (no). The patient's MRI report indicates a relatively stable clinical status, with no major complications such as thrombus, significant arrhythmias, or other serious cardiac interventions, which often precede the need for transplantation. Additionally, the absence of significant medical interventions such as ECMO or a history of severe heart failure (evidenced by a NYHA class not being specified) suggests that their cardiac function is being adequately managed. Overall, the lack of severe complications and a stable status lead to the prediction that a heart transplant was not necessary at this time.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, it is reasonable to predict that the patient does not have a history of pacemaker placement (no). The patient has not exhibited significant electrical or mechanical complications traditionally associated with single-ventricle physiology post-Fontan, as indicated by the absence of atrial tachyarrhythmias, sustained ventricular tachyarrhythmias, or any history of cardiac arrest, which often necessitates pacing interventions. Furthermore, the patient is currently stable, as denoted by the ""Current NYHA class: yes"" and does not require additional cardiac drugs such as beta-blockers, which could suggest ongoing issues that would warrant device placement. Hence, the absence of these complications and the stable medication regimen suggest that pacemaker placement is unnecessary for this patient.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, it is reasonable to predict that the patient has not died (no). The patient's history indicates no significant complications common in single-ventricle patients who have undergone Fontan surgery, such as stroke, thrombus, or chronic issues like protein-losing enteropathy or plastic bronchitis. Additionally, the absence of a heart transplant and other severe outcomes alongside only minor medications suggests that the patient is stable. The current NYHA class and the use of anticoagulants for potential thrombosis prevention further indicate that the patient's heart function is being monitored and managed appropriately, contributing to overall survival.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I predict that the patient does **not** have a history of ascites (> trace). The patient's MRI report and surgical history indicate that there are no significant complications following the Fontan surgery, such as protein-losing enteropathy, hepatic issues, or fluid retention-related problems, which are often associated with ascites. Additionally, the absence of pleural effusions and liver dysfunction signs further supports this prediction, suggesting that the patient has maintained a relatively stable clinical status without significant congestive symptoms.",1,0
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, I predict that the patient **does have a diagnosis of seizures requiring antiepileptic medications**. The history of non-perioperative stroke indicates potential neurological complications, which may predispose the patient to seizures. Additionally, the presence of intracardiac thrombus and the patient's history of hemoptysis could suggest underlying vascular challenges that may affect cerebral circulation, further increasing the risk of seizure activity. Lastly, the patient's ongoing management with psychological medications and beta-blockers could align with a broader set of neurological issues, emphasizing the need for careful monitoring for seizures.",0,0
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided data, it is reasonable to predict that the patient **does not have a history of ascites (> trace)**. The patient's MRI report and surgical history indicate significant complications, including a history of thrombus and hepatocellular carcinoma, but there are no documented symptoms or complications related to ascites or fluid retention. Furthermore, the absence of chronic pleural effusions and renal dysfunction also suggests that fluid overload and related conditions like ascites are less likely. Given the patient's other medical issues relating to hepatic complications, any ascites that may arise is not indicated in the data.",0,1
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Given the data provided, my prediction is that the patient did not receive a heart transplant (no). The patient has a history of significant complications, including intracardiac thrombus, hepatocellular carcinoma, and hemoptysis, which may lead to a deteriorating clinical picture. Additionally, the presence of atrial tachyarrhythmias and a history of non-sustained strokes suggests ongoing cardiovascular instability, which may make transplantation less viable. The presence of ascites and elevated liver fibrosis also indicates significant end-organ dysfunction, which typically complicates candidacy for heart transplantation. Overall, these findings suggest a high-risk profile that may preclude transplantation eligibility.",1,0
BCH-GUYCOR-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information about the patient's clinical history, I would predict that the patient has not died. The presence of an intracardiac thrombus and history of non-perioperative stroke may indicate some level of risk for adverse outcomes, but the patient has not experienced cardiac arrest or major acute complications requiring emergency interventions. Additionally, the patient’s ongoing management includes the use of beta blockers and diuretics, suggesting active treatment for heart failure symptoms, which may help stabilize their condition. Given the absence of more severe complications and no report of deterioration in functional status, it is reasonable to conclude that the patient is still alive.",1,0
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, I predict that the patient does have a history of pacemaker placement (yes). The presence of atrial tachyarrhythmias and the patient undergoing a post-Fontan electrophysiologic study suggest significant electrical conduction issues that may require intervention. Additionally, the patient's history of interventions, including elective cardioversion and ongoing symptoms that could affect heart rhythm, indicates a likelihood of needing a pacemaker to manage these complications and maintain an appropriate heart rate and rhythm. Therefore, given the complexity of their cardiac history and the manifestations of arrhythmias, it is reasonable to conclude that pacemaker placement may have been necessary in this patient's management.",0,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the information provided, I predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient's medical history shows no documented instances of neurological events such as strokes or transient ischemic attacks, which suggest a lower likelihood of seizures developing. Additionally, the absence of other signs of serious complications post-surgery, coupled with their current NYHA class status and medication regimen, indicates stability without the need for seizure management. Therefore, the overall clinical picture does not support a diagnosis of seizures requiring antiepileptic treatment.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I predict that the patient does **not** have a history of ascites (> trace). This conclusion is supported by the absence of significant clinical issues typically associated with the development of ascites in Fontan patients, such as protein-losing enteropathy or renal dysfunction. Furthermore, the patient's MRI report does not indicate any abnormalities suggestive of hepatic congestion or fluid accumulation, which are frequently linked to ascites. Overall, the patient's comprehensive medical history and lack of related symptoms suggest they are unlikely to have experienced ascites.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, I predict that the main patient did not receive a heart transplant. The absence of significant complications such as stroke, cardiac arrest, or the requirement for aggressive interventions like ECMO or defibrillator use indicates stability in the patient's condition post-surgery. Additionally, the current management consisting of anticoagulation, ACE-I/ARB, diuretics, and pulmonary vasodilators suggests that the patient is being successfully treated for their condition, potentially avoiding further deterioration that would necessitate transplantation. The overall profile reflects a stable status that reduces the likelihood of needing a heart transplant at this time.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, the prediction for the missing clinical outcome—whether the patient has died—would be ""no."" The patient demonstrates a comprehensive absence of severe complications typically associated with poor outcomes in single-ventricle patients who have undergone Fontan surgery, such as thrombus formation, significant arrhythmias, and organ dysfunction (e.g., liver or renal issues). Additionally, the patient is currently receiving appropriate cardiac medications and has stable NYHA class status, which suggests they are managing well clinically. Given these factors, it is reasonable to conclude that the patient has not died.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, I would predict that the patient does **not** have a history of pacemaker placement (no). The patient exhibits no signs of significant arrhythmias, such as atrial or ventricular tachyarrhythmias, as well as no previous cardiac arrests or indications of symptomatic bradycardia, all of which would typically necessitate pacemaker intervention. Additionally, the patient is currently maintained on multiple cardiovascular medications, including anticoagulants and pulmonary vasodilators, which can be indicative of close monitoring of cardiac status rather than a need for device-based rhythm management. Overall, the absence of major cardiac events and the current treatment regimen suggest a stable hemodynamic state that does not warrant a pacemaker.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I would predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The absence of significant neurological events, such as stroke or transient ischemic attacks, suggests that the patient’s neurological status is likely stable. Additionally, while the patient has a history of atrial tachyarrhythmias and non-sustained ventricular tachyarrhythmias, these heart rhythm issues do not typically correlate with seizure activity. The overall clinical picture, including the patient's lack of prior critical events and current management approaches, indicates a lower likelihood of seizure diagnosis needing treatment.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I predict that the patient does **not** have a history of ascites (> trace). The main patient has a history of significant cardiac arrhythmias that suggest a certain level of cardiovascular stress, but crucially, they have no recorded history of complications typically associated with the Fontan procedure, such as pleural effusions or other gastrointestinal issues that could lead to ascites. Additionally, the absence of any liver dysfunction indicators further supports that the patient is unlikely to have developed ascites, as such condition often arises from liver health problems or significant volume overload, none of which are indicated in their medical history.",1,0
BCH-KATNAT-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, it is reasonable to predict that the patient has not died (no). The absence of severe complications such as stroke, cardiac arrest, major thrombus, or significant functional decline indicates a relatively stable clinical status. Although the patient exhibits some arrhythmias (atrial tachyarrhythmias and non-sustained ventricular tachycardias), these are common in single-ventricle patients and are often managed effectively without leading to mortality. Additionally, the patient is being treated with beta blockers and anticoagulants, which further supports ongoing management of their condition without life-threatening outcomes.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the information provided, I predict that the patient does **not** have a history of pacemaker placement (no). The main factors influencing this prediction include the patient's history of atrial tachyarrhythmias and non-sustained ventricular tachyarrhythmias, which are often treated with medications and may not necessitate the implantation of a pacemaker if the episodes are well-managed. Additionally, the absence of significant bradycardia or symptoms suggesting severe conduction disorders, alongside the fact that the patient is currently on a beta blocker, implies that there may not have been a need for pacing support. Furthermore, there is no documented history of severe arrhythmias or syncope that would typically lead to the placement of a pacemaker, reinforcing the reasoning that this patient likely does not require one.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, it is predicted that the patient did not receive a heart transplant (no). The absence of significant complications typically associated with single-ventricle patients after Fontan surgery, such as major thrombus formation, renal dysfunction, pleural effusions, and cardiac arrest, suggests a relatively stable clinical state. However, the patient's history of persistent atrial tachyarrhythmias and non-sustained ventricular tachyarrhythmias could indicate some ongoing cardiac stress or dysfunction, but not to the extent that would necessitate transplantation. Furthermore, the patient's current medication regimen does not indicate an advanced stage of heart failure that usually prompts consideration for a transplant, reinforcing the prediction that transplantation was not necessary.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, it can be predicted that the patient has not died (no). The absence of major complications, such as a history of stroke, cardiac arrest, or significant organ dysfunction, suggests a relatively stable clinical status post-Fontan surgery. Furthermore, the patient is actively being managed with multiple cardiac medications, including beta-blockers and anticoagulants, which indicates ongoing monitoring and intervention rather than a terminal condition. Additionally, the lack of severe events in their surgical history and the fact that they are not listed for heart transplant imply an ongoing chronic but manageable health status.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, it is predicted that the patient did **not** receive a heart transplant. The patient exhibits no history of acute complications that would typically lead to a heart transplant, such as significant arrhythmias (with only non-sustained episodes reported), nor is there evidence of end-organ dysfunction (e.g., liver dysfunction, renal dysfunction). Additionally, the absence of severe complications like stroke, thrombus, or cardiogenic events suggests stable post-operative condition following the Fontan procedure, which generally indicates that a heart transplant would not be immediately necessary. Overall, the clinical history reflects a patient who is managing their condition with medications without requiring the escalation to transplant.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, it is reasonable to predict that the patient does not have a history of ascites (> trace) (no). The patient has been assessed for multiple potential complications following their Fontan surgery, and there is no reported history of protein-losing enteropathy, significant pleural effusions, or liver dysfunction—all of which are commonly associated with the development of ascites. Furthermore, the patient's current medications include diuretics, which are often used to manage fluid overload conditions; the lack of other complications from the imaging findings reinforces the idea that ascites is unlikely in this case. The absence of any renal dysfunction or significant cardiac issues also supports the conclusion that ascites is not present.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, the prediction for whether the patient has a diagnosis of seizures requiring antiepileptic medications is **no**. The absence of documented history related to neurological events, such as strokes or transient ischemic attacks, alongside the lack of any current treatments typical for seizure management, suggests that the patient is unlikely to have experienced significant seizure activity necessitating antiepileptic medications. Additionally, the presence of atrial tachyarrhythmias and non-sustained ventricular tachyarrhythmias does indicate cardiac instability, but there is no direct correlation to seizures that would necessitate further neurological interventions or treatments in this case.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, it is likely that the patient does **not** have a history of pacemaker placement. Although the patient experiences atrial tachyarrhythmias and non-sustained ventricular tachyarrhythmias, there is no mention of sinus node dysfunction, which is often a primary indication for pacemaker placement. Additionally, the patient has undergone a post-Fontan electrophysiological study and has been treated with ivabradine for exaggerated sinus node behavior, suggesting that the current management of arrhythmias may be effectively controlled without the need for a pacemaker. Therefore, given these considerations, a history of pacemaker placement is unlikely.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided clinical data of the main patient, it is reasonable to predict that the patient has not died (answer: no). Although the patient has a history of significant complications such as an intracardiac thrombus, arrhythmias, and the need for anticoagulant therapy, there are no recorded instances of cardiac arrest, stroke, or major organ failure. Additionally, the absence of serious long-term complications, such as protein-losing enteropathy or other life-threatening conditions commonly associated with single-ventricle patients post-Fontan, suggests that the patient's overall clinical status may still be stable. Hence, the absence of extreme deterioration would support the classification of the patient as alive.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, it is reasonable to predict that the patient does not have a history of ascites (> trace) (no). The patient's MRI report and surgical history indicate the presence of intracardiac thrombus and atrial tachyarrhythmias, but there are no documented histories of pleural effusions, hemoptysis, or other conditions typically associated with the development of ascites, such as liver dysfunction or significant fluid overload. Furthermore, the absence of any signs of hepatic issues (like elevated liver fibrosis or liver carcinoma) suggests that the liver's function has been stable, making it less likely that the patient would exhibit signs of ascites.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, it is reasonable to predict that the patient did not receive a heart transplant. The presence of an intracardiac thrombus and atrial tachyarrhythmias suggests a significant level of cardiac dysfunction; however, the absence of chronic complications associated with heart failure or other severe end-stage cardiac conditions—such as sustained ventricular tachyarrhythmias or the need for ECMO—indicates that the patient's condition, while complicated, is being managed and has not yet necessitated transplantation. Additionally, the lack of any documented severe comorbidities, like renal dysfunction or hepatocellular carcinoma, further supports that the patient might still be a candidate for ongoing management rather than immediate transplantation.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided patient data, it is reasonable to predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The absence of any history of stroke, transient ischemic attacks, or peri-operative cardiac arrests suggests a lower likelihood of neurological complications that could lead to seizures. Additionally, while the patient has a history of atrial tachyarrhythmias and sinus node dysfunction, these cardiovascular issues do not directly indicate a predisposition to seizures. Therefore, given the lack of neurological events and other related factors, it is unlikely that the patient requires antiepileptic medications.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information regarding the patient's clinical history and MRI report, it is likely that the patient has a history of pacemaker placement (yes). The patient presents with significant cardiac issues, including a history of atrial tachyarrhythmias and sinus node dysfunction, which often necessitate the use of a pacemaker to manage bradyarrhythmias or maintain adequate heart rhythm. Additionally, the presence of an intracardiac thrombus could suggest underlying electrical or mechanical complications that might also increase the patient's risk for arrhythmias, further supporting the need for a pacemaker. Thus, while there is no direct mention of pacemaker placement, the patient's complex cardiac profile strongly indicates it would be a reasonable intervention.",0,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, I predict that the patient did not receive a heart transplant (no). The patient's MRI report and surgical history indicate no significant complications despite the complex nature of single-ventricle physiology, with the absence of critical events such as stroke, thrombus, or major arrhythmias, which are often indicators for transplantation. Additionally, the patient is currently stable, evidenced by their non-deteriorating NYHA class status and absence of significant comorbidities (e.g., protein-losing enteropathy, renal dysfunction). These factors suggest a relatively stable clinical course, reducing the likelihood that transplantation was necessary.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I predict that the patient does **not** have a history of ascites (> trace). The absence of multiple complications commonly associated with Fontan patients, such as protein-losing enteropathy, chylous pleural effusions, or elevated liver fibrosis tests, suggests that the patient has had a relatively stable clinical course. Additionally, the patient's current NYHA class status, use of diuretics, and lack of significant cardiac complications further support the idea that fluid retention issues such as ascites are unlikely. Overall, these factors indicate a lower likelihood of ascites in this case.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, it is reasonable to predict that the patient does **not** have a history of pacemaker placement (no). The patient's current medication regimen includes various cardiac-supportive medications such as anticoagulants, ACE inhibitors, diuretics, and beta blockers, indicating an ongoing management of potential cardiac issues without invasive interventions. Additionally, there is no documented history of significant arrhythmias or sustained ventricular tachycardia, which would typically necessitate the placement of a pacemaker. The absence of both urgent interventions like ECMO and grace period problems related to heart rhythm suggests that the patient's heart should be stable enough to not require pacing devices.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, it is reasonable to predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications. This reasoning is supported by the absence of any noted history of significant neurological issues, including strokes or transient ischemic attacks, which would typically be associated with an increased risk of seizure activity. Additionally, the overall absence of serious complications such as thrombus, arrhythmias, or major surgeries involving the central nervous system suggests a lower likelihood of seizure disorders. The patient's active management with anticoagulants and pulmonary vasodilators, along with regular monitoring, may also contribute to their neurological stability.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided patient data, I predict that the missing clinical outcome, ""Has the patient died?"" is **no**. The patient has no significant history of complications typically associated with poor outcomes in single-ventricle patients post-Fontan surgery, such as heart failure, thrombus events, or significant arrhythmias. Additionally, the absence of severe comorbidities and the current use of medications typically used to manage and optimize cardiac function (such as ACE inhibitors, diuretics, and beta-blockers) suggests that the patient's condition is stable. Overall, the comprehensive management and lack of critical health events strongly indicate that the patient has survived post-surgery.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, the patient has a history of atrial tachyarrhythmias and has required emergent cardioversion due to significant tachycardia. These factors indicate ongoing cardiac complications that are often associated with worsening heart function in single-ventricle patients post-Fontan surgery. Given that the patient is on anticoagulation and possibly other heart failure management medications, it suggests a decline in heart function. Therefore, it is reasonable to predict that the patient has not yet received a heart transplant; the answer is ""no."" This conclusion aligns with the absence of documented end-stage heart failure or transplantation history in the details provided.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the information provided, it is reasonable to predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications (no). The patient has a significant history of atrial tachyarrhythmias and emergent cardioversion but lacks any documented history of seizures or transient ischemic attacks, which are often precursors to seizure activity in this patient population. Additionally, there are no indications of neurological issues or abnormalities in the MRI report that typically accompany seizure disorders. This absence of relevant neurological complications leads to the conclusion that seizures are unlikely to be a concern for this patient.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, it is likely that the patient does not have a history of pacemaker placement (no). The patient's MRI report indicates a significant history of atrial tachyarrhythmias and an emergent cardioversion event, which suggests the presence of arrhythmias that could potentially warrant pacemaker intervention; however, the absence of information regarding sustained ventricular tachyarrhythmias and sinus node dysfunction further supports that a pacemaker might not have been deemed necessary. Additionally, the patient has been treated with antiarrhythmic medications, anticoagulants, and an electrophysiologic study, suggesting that their arrhythmias are being managed conservatively, thus reducing the likelihood of requiring a pacemaker as a permanent solution.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided patient data, I predict that the patient does **not** have a history of ascites (> trace). The patient's surgical history indicates a stable postoperative course with no significant complications, such as protein-losing enteropathy or pleural effusions, which are often associated with ascites. Additionally, the absence of significant liver dysfunction, as evidenced by a lack of history for elevated liver fibrosis tests or hepatocellular carcinoma, supports this prediction. Furthermore, the fact that the patient is on diuretics and anticoagulation suggests a careful management of fluid status, further decreasing the likelihood of ascites.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, I predict that the patient has **not died**. The patient has a history of cardiac arrhythmias, specifically atrial flutter, and has required emergent cardioversion; however, there are no reports of sustained ventricular tachyarrhythmias or major complications such as heart transplant or significant organ dysfunction. Furthermore, there is no indication of life-threatening conditions such as thrombus or stroke, which, along with the absence of severe symptoms following Fontan surgery and ongoing management with anticoagulants, suggests that the patient remains stable. Therefore, it seems likely that the patient continues to survive despite the cardiovascular challenges they face.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, it is predicted that the patient has not died (no). The patient has a history of atrial tachyarrhythmias, but no other serious complications or events such as heart failure, major thromboembolic events, or significant organ dysfunction are reported, indicating a stable status. Additionally, the absence of chronic complications like protein-losing enteropathy, significant pleural effusions, or other acute events supports the likelihood of survival post-Fontan surgery. Overall, the patient's current management with anticoagulation, beta-blockers, and diuretics suggests ongoing treatment and monitoring, further implying a stable condition conducive to survival.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, it is reasonable to predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications. The patient has no history of significant neurological events such as strokes or transient ischemic attacks, which often predispose individuals to seizure disorders. Furthermore, the absence of major complications post-surgery, such as cardiac arrest or thrombus, further suggests that the patient's neurological status has remained stable. Given that the patient is on various medications, including beta blockers and antidepressants, but there is no indication of antiepileptic usage, it supports the likelihood that seizures are not a concern for this patient.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, it is likely that the patient does have a history of pacemaker placement (yes). This conclusion is drawn from the patient's history of atrial tachyarrhythmias and the need for elective cardioversion, which suggests significant arrhythmic issues that may necessitate the use of a pacemaker for rate control or management of the underlying rhythm. Additionally, the absence of sustained ventricular arrhythmias and a normal GFR indicates some degree of cardiac stability, but the patient's cardiac history raises concerns about potential arrhythmias that a pacemaker could help mitigate. Therefore, considering these patterns and the need to manage arrhythmias effectively in post-Fontan patients, a history of pacemaker placement would be a reasonable prediction.",0,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data, it is reasonable to predict that the patient did not receive a heart transplant (no). The patient does not show significant complications such as protein-losing enteropathy, thrombus formation, or severe arrhythmias that frequently lead to the need for transplantation. While the patient does have a history of atrial tachyarrhythmias, they have been managed with antiarrhythmic therapy (e.g., beta blockers) and elective cardioversion, suggesting stable cardiac function. Additionally, the absence of severe heart failure symptoms, as indicated by the lack of advanced NYHA class indications, further supports the likelihood of avoiding transplantation.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I would predict that the patient does **not** have a history of ascites (> trace). The absence of significant cardiovascular or renal complications, such as elevated liver fibrosis tests and renal dysfunction, suggests they have maintained a relatively stable hemodynamic status post-Fontan surgery. Additionally, the patient reports no history of pleural effusion or protein-losing enteropathy, which further supports the idea that fluid retention or accumulation, such as ascites, is unlikely. As such, the absence of these complications, combined with stable clinical parameters, indicates that a history of ascites is improbable for this patient.",1,0
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, I would predict that the patient does not have a history of pacemaker placement (no). The patient has a history of intracardiac thrombus and is on anticoagulant therapy, which may suggest some degree of hemodynamic instability, but there is no indication of any significant arrhythmias or conduction issues that typically warrant pacemaker placement. Additionally, the absence of any listed arrhythmias, including atrial fibrillation or sustained ventricular tachyarrhythmias, further supports the likelihood that a pacemaker has not been necessary for this patient’s condition post-Fontan surgery.",1,0
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided information, I predict that the patient does not have a history of ascites (> trace) (no). The patient's MRI report and surgical history indicate significant events such as the presence of an intracardiac thrombus and elevated liver fibrosis, which may suggest potential complications related to circulation and liver health. However, the absence of pleural effusions, protein-losing enteropathy, and renal dysfunction implies a relatively stable fluid balance and absence of significant systemic fluid retention or complications that often accompany ascites. Thus, it is reasonable to conclude that ascites is not a current issue for this patient.",0,1
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided MRI report and clinical history, it is reasonable to predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications. The absence of a history of stroke, transient ischemic attacks, and peri-operative cardiac arrests suggests a relatively low risk for neurological complications. Additionally, while the patient does have a history of intracardiac thrombus and elevated liver fibrosis tests, there is no indication of neurological sequelae such as seizures, which would typically arise from significant vascular or metabolic issues. Therefore, given the overall clinical context, the patient is likely seizure-free and does not require antiepileptic treatment.",1,0
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Given the patient's history of intracardiac thrombus and elevated liver fibrosis markers, along with the presence of ascites, it is likely that their clinical condition is complex and could be deteriorating. These factors often signify significant complications related to single-ventricle physiology and the challenges following Fontan surgery. Additionally, the need for anticoagulation suggests a heightened risk for thromboembolic events, which can complicate overall management and affect the timing or consideration for transplantation. Therefore, it is reasonable to predict that the patient did not receive a heart transplant, as these ongoing issues may have precluded them from being suitable candidates for such an intervention.",1,0
BCH-NUSPIN-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, it is reasonable to predict that the patient has not died. The patient has a history of intracardiac thrombus, positive liver fibrosis tests, and ascites, which are indicative of potential complications. However, there are no indications of severe acute events such as cardiac arrest or significant arrhythmias that could suggest imminent risk to their life. Moreover, the absence of other severe conditions or requiring interventions typically associated with high mortality in these patients implies that they are managing their condition adequately. Therefore, the current clinical profile suggests ongoing monitoring and management rather than an imminent fatal outcome.",1,0
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,"[' Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. \n Has the patient died? yes\n If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest\n']","Based on the patient's data, it is likely that the patient has not died (no). Although there is a documented history of intracardiac thrombus and atrial fibrillation, which are significant risk factors for morbidity and mortality in single-ventricle patients, there are no indications of severe complications such as stroke, cardiac arrest, or significant respiratory issues reported that would suggest a terminal condition. Additionally, the absence of a heart transplant and the ongoing management with anticoagulants and diuretics implies that the patient is still receiving active treatment, which would generally indicate ongoing survival. The lack of any acute life-threatening events in the provided history further supports this prediction.",0,1
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided patient data, it is reasonable to predict that the patient does not have a history of pacemaker placement (No). The patient has documented episodes of atrial fibrillation and required elective cardioversion, suggesting arrhythmia management; however, there is no indication of sustained ventricular tachyarrhythmias or cardiac arrest that would typically necessitate a pacemaker. Moreover, the history of antiarrhythmic management with anticoagulants suggests a degree of ongoing monitoring and treatment but does not confirm a need for permanent pacing support, especially in the absence of significant sinus node dysfunction or evidence of bradyarrhythmias that would warrant such intervention.",1,0
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the information provided, it is likely that the patient does **not** have a history of ascites (> trace). While the patient has several comorbidities such as a history of intracardiac thrombus and arrhythmias, there is no indication of complications typically associated with ascites, such as liver dysfunction or significant fluid accumulation issues. Moreover, the absence of liver disease indicators (e.g., elevated liver fibrosis tests or a history of hepatocellular carcinoma) further supports this prediction. Therefore, it is reasonable to conclude that the patient does not have a significant history of ascites.",0,1
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, I predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications (answer: **no**). The patient's history reveals significant cardiac issues, including atrial fibrillation and a prior history of thrombus, which are more closely associated with risks of arrhythmias rather than seizures. Although the patient experienced serious complications leading to sudden death, there is no documented history of neurologic events such as transient ischemic attacks, peri-operative strokes, or other indications that would raise concern for seizure activity. Additionally, there is no mention of any prior seizure episodes or the need for antiepileptic medications, suggesting a lack of evidence for that diagnosis.",1,0
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the available information, it is likely that the patient did not receive a heart transplant. The patient has a complex medical history, including episodes of atrial fibrillation, a first intracardiac thrombus, and a sudden death attributed to malignant arrhythmia. These factors suggest significant cardiac instability, making the patient a poor candidate for transplantation, as stable hemodynamics are generally required. Additionally, the lack of information regarding ongoing assessments or referrals for transplantation further supports the conclusion that a transplant was not pursued or deemed possible in this case.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, it is unlikely that the patient has a history of ascites (> trace). The patient's MRI report shows evidence of cardiac complications, including arterial tachyarrhythmias and thrombus formation, but does not indicate any issues related to liver function or fluid overload, which would often correlate with ascites. Additionally, the absence of significant liver fibrosis, hepatocellular carcinoma, and renal dysfunction, as well as no mention of fluid retention symptoms or respiratory distress that could suggest right heart failure, further supports the conclusion that ascites is not present. Thus, the prediction is that the answer is ""no.""",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided patient data, I predict that the missing clinical outcome, ""Does the patient have a diagnosis of seizures requiring antiepileptic medications?"" is **no**. The patient's history indicates no prior instances of stroke or transient ischemic attacks, which often correlate with seizure activity in patients with complex cardiac histories. Additionally, their cardiac complications appear to primarily involve arrhythmias rather than neurological events, and there is no mention of neurologic symptoms or investigations that would typically accompany a diagnosis requiring antiepileptic medication. Thus, the absence of these indicators suggests that seizures are unlikely.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the MRI report and surgical history provided, it is likely that the patient has not received a heart transplant (Prediction: No). The patient has a documented history of atrial tachyarrhythmias and an intracardiac thrombus, which are significant complications that can complicate the clinical course following Fontan surgery. However, there is no evidence of severe liver dysfunction, renal dysfunction, or other critical indications that typically lead to heart transplantation in this population. Additionally, the patient is currently stable with anticoagulation and anti-platelet therapy, which may indicate ongoing management rather than progression to transplant mode.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided MRI report and surgical history, I predict that the patient has not died. The patient displays a history of atrial tachyarrhythmias and has required emergent cardioversion, which indicates ongoing management of cardiac complications rather than terminal decline. Additionally, the absence of severe comorbidities such as a history of significant thromboembolic events or strokes, along with stable hemodynamics following arrhythmogenic episodes, suggests a degree of resilience. Furthermore, the ongoing use of anticoagulants and heart failure medications implies active management of their condition, rather than an end-stage scenario.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, it is likely that the patient does **not** have a history of pacemaker placement. The patient's history shows atrial tachyarrhythmias and the need for emergent cardioversion, which indicates arrhythmia management; however, there is no documentation suggesting sustained or recurrent issues that would necessitate a pacemaker. Additionally, the absence of sinus node dysfunction or prior electrophysiologic studies further suggests that the cardiac conduction system has not warranted permanent pacing measures at this time. Therefore, while the patient has experienced significant arrhythmias, the current clinical status and interventions do not indicate a need for a pacemaker.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, I predict that the patient has **not died**. The main patient's surgical history is devoid of serious complications often associated with poor outcomes, such as heart transplant, significant thrombus formation, or severe liver-related issues, all of which suggest stability in their condition. Additionally, the absence of significant arrhythmias, the current NYHA class (which implies a functional status), and the use of anticoagulants indicate proactive management of potential risks. Overall, these factors point towards a favorable prognosis regarding survival following Fontan surgery.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I would predict that the patient does **not** have a history of ascites (> trace). The patient has no reported diagnosis of protein-losing enteropathy or liver dysfunction, which are often associated with fluid retention and the development of ascites in Fontan patients. Additionally, the absence of other complications such as pleural effusions and cardiac arrhythmias suggests a relatively stable hemodynamic status. Therefore, it is reasonable to conclude that the patient has not experienced ascites in this context.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data, I predict that the patient did not receive a heart transplant (no). The absence of significant complications—such as thrombus formation, cardiac arrhythmias, and other serious conditions like protein-losing enteropathy or severe renal issues—suggests that the patient's condition is stable and well-managed post-Fontan. Additionally, the fact that the patient is not on a diuretic or other heart failure medications typically associated with post-operative deterioration further supports the idea that a transplant may not have been necessary. These factors indicate a relatively favorable prognosis, making a heart transplant less likely.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided clinical history and MRI report, it is predicted that the patient does **not** have a history of pacemaker placement. The absence of significant arrhythmias, such as sustained ventricular tachycardia or atrial fibrillation, alongside the patient's stable current NYHA class and lack of interventions related to pacing or electrophysiology, indicates that there may not have been a clinical necessity for a pacemaker. Additionally, the patient’s use of anticoagulants suggests a focus on preventing thrombotic events rather than addressing electric conduction issues typically managed by pacemakers. Thus, it is reasonable to infer that the clinical profile does not support the need for a pacemaker placement.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided patient data, it is reasonable to predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications. The patient exhibits no history of stroke or transient ischemic attacks, which are often associated with an increased risk of seizures in patients with a significant cardiac history. Additionally, the absence of any neurological events during or after surgery further supports the likelihood that the patient's neurological status is stable and does not warrant antiepileptic treatment. Furthermore, there are no indications in the historical and current medical data suggesting any conditions that would typically lead to seizures.",1,0
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? yes\n Did the patient receive a heart transplant? yes\n'],"Based on the provided information, it is likely that the patient did not receive a heart transplant. The patient has a complex history, including episodes of arrhythmias and significant complications such as protein-losing enteropathy and pleural effusions, which can be indicative of advanced heart failure. However, there is no record of intracardiac thrombus, severe liver dysfunction, or sustained ventricular tachyarrhythmias, which typically complicate the decision for transplantation. Furthermore, the patient's continued management with anticoagulants and diuretics suggests a strategy to optimize their remaining cardiac function rather than indicating an imminent transplant necessity.",0,1
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Given the patient’s history of emergent cardioversion and defibrillation due to arrhythmogenic events following Fontan surgery, it suggests that there have been significant rhythm disturbances. The presence of atrial tachyarrhythmias, combined with heart block after the SANO procedure, indicates a potential requirement for a pacemaker to manage these electrical conduction issues. Additionally, the need for anticoagulation therapy often accompanies the use of a pacemaker, particularly in patients with arrhythmias to prevent thromboembolic events. Therefore, it is reasonable to predict that the patient does have a history of pacemaker placement (yes).",0,0
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided clinical history of the main patient, it is reasonable to predict that the patient has not died. Although the patient has a complex clinical background, including a history of heart transplant, protein-losing enteropathy, pleural effusions, and atrial tachyarrhythmias, there is no indication of critical acute events, such as sustained arrhythmias or major thromboembolic complications leading to mortality. Additionally, the presence of ongoing medical management with anticoagulants, diuretics, and beta blockers suggests that the patient is being actively monitored and treated, which could contribute to maintaining stability in their condition. Therefore, given this context, it is likely that the patient is alive.",1,0
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the information provided, I would predict that the patient does have a history of ascites (> trace) — therefore, the answer is yes. The patient has a diagnosed history of protein-losing enteropathy and significant pleural effusions, both of which can be associated with fluid retention and abdominal issues such as ascites in single-ventricle patients who have undergone Fontan surgery. Additionally, the presence of both pleural effusions and protein-losing enteropathy suggests a chronic condition that often leads to fluid accumulation, including in the abdominal cavity. Thus, these findings imply a higher likelihood of ascites in this patient.",1,1
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the information provided, it is reasonable to predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient has a complex cardiac history that includes significant interventions and complications such as protein-losing enteropathy and various arrhythmias, but there is no documented history of neurological events, such as strokes or transient ischemic attacks, that might suggest seizures. Furthermore, the patient's history does not include indications of electrolyte imbalances or other risk factors commonly associated with seizure disorders. Given this background, it seems unlikely that seizures requiring treatment with antiepileptic medications are a concern for this patient.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, I would predict that the patient does not have a history of pacemaker placement (no). The patient's MRI findings suggest the presence of intracardiac thrombus and thrombosed lung artery, but there are no indications of sustained arrhythmias or any cardiac arrest episodes that would typically necessitate a pacemaker. Additionally, the absence of any mention of arrhythmogenic complications, and current antiarrhythmic medications implies that the patient may not have experienced significant electrical conduction issues warranting a pacemaker. Thus, the overall clinical history does not support the need for a pacemaker.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data, it is likely that the patient did not receive a heart transplant. The absence of severe complications such as significant renal dysfunction, protein-losing enteropathy, or recurrent thrombotic events, alongside the fact that the patient is currently on anticoagulation therapy and other heart failure medications (like ACE inhibitors and diuretics), suggests a relatively stable condition post-Fontan. Additionally, the patient does not have any histories of major complications like cardiac arrest, atrial tachyarrhythmias, or significant pleural effusions, which could typically complicate or necessitate the consideration for a transplant. Thus, given the current clinical status and treatments, it is reasonable to conclude that heart transplantation was not required.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I predict that the patient does not have a history of ascites (> trace), indicating a ""no"" outcome. The patient has not reported any history of protein-losing enteropathy or chylous pleural effusion, both conditions that can contribute to fluid retention and ascites in post-Fontan patients. Additionally, the absence of symptoms such as pleural effusions or renal dysfunction further suggests that this patient has maintained a relatively stable hemodynamic status, which is typically associated with lower risk for complications such as ascites. Therefore, the combination of these factors points towards the absence of significant fluid accumulation in this patient’s clinical picture.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I would predict that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications. The patient has a documented history free of significant neurological events, such as strokes or transient ischemic attacks, which reduces the likelihood of seizure disorders. Additionally, the absence of any mention of episodes suggestive of seizures or related neurological concerns in the patient's medical history further supports this conclusion. Finally, the patient does not have any listed medications that would typically be associated with seizure management, reinforcing the prediction that seizures are not a current clinical issue.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, I predict that the patient has not died (no). Although the patient has a history of intracardiac thrombus, which could pose serious risks, there are no reported episodes of severe complications such as cardiac arrest, stroke, or significant organ dysfunction. Additionally, the patient is currently on anticoagulant therapy and other medications that may help manage potential complications, which suggests proactive management of their condition. The absence of key adverse events and the ongoing treatment indicate that the patient's status is being adequately monitored and managed.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, it is reasonable to predict that the patient did not receive a heart transplant (no). The absence of complications commonly associated with Fontan physiology, such as protein-losing enteropathy, plastic bronchitis, significant arrhythmias, and major thromboembolic events, suggests that the patient is managing their condition well post-surgery. Additionally, the indication of stable current NYHA class and lack of severe systemic or cardiac manifestations further support the idea that the patient may not have reached a point of needing transplant intervention. Overall, the positive clinical status and absence of critical complications point away from the necessity for a heart transplant.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the comprehensive data provided, I would predict that the patient has not died (no). The absence of severe complications such as thrombus formation, strokes, or significant arrhythmias, along with their current status of receiving anticoagulant therapy and being on an antidepressant regimen, suggests a level of stability. Furthermore, the lack of any chronic complications such as protein-losing enteropathy or plastic bronchitis supports a more favorable health status post-Fontan surgery. Overall, these observations indicate that the patient is managing well and not facing life-threatening issues at this point in time.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications. This conclusion is supported by the absence of any significant neurological events such as strokes or transient ischemic attacks, which are commonly associated with seizure disorders. Additionally, the patient’s current medications do not include any antiepileptic drugs, and there is no history of neurological dysfunction noted in the report. Overall, the overall clinical stability reflected in the patient's surgical history and MRI findings suggests a low likelihood of seizure activity necessitating treatment.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, the prediction for whether the patient has a history of pacemaker placement is **no**. The patient has no recorded history of key complications typically associated with the need for pacemaker implantation, such as sustained arrhythmias (e.g., ventricular tachycardia, atrial fibrillation), sinus node dysfunction, or other cardiac arrests. Additionally, the patient's current NYHA class denotes stable cardiac function and does not indicate advanced heart failure or significant rhythm disturbances that would necessitate a pacemaker. Given the lack of significant cardiac events or conditions in the history that typically lead to pacemaker placement, it is reasonable to conclude that the patient does not have such a history.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, it is reasonable to predict that the patient does not have a history of ascites. The absence of critical complications typically associated with Fontan physiology, such as protein-losing enteropathy, pleural effusions, and any form of renal dysfunction, suggests a stable clinical condition. Moreover, the patient has not presented symptoms or a history indicative of fluid overload or significant intra-abdominal complications, which are often linked with ascites. Therefore, the patient's clinical stability and lack of associated complications point towards a ""no"" for the history of ascites.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data for the main patient, it is reasonable to predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications. The patient has no significant history of neurological events such as stroke or transient ischemic attacks, which are often associated with seizure disorders. Furthermore, there is no indication of any other risk factors or comorbidities that might predispose the patient to seizures, such as cardiac arrhythmias or significant stressors that could contribute to neurological episodes. Therefore, it appears that the patient's clinical history supports a negative prediction for epilepsy or seizure-related diagnoses.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the information provided, I predict that the patient does **not** have a history of pacemaker placement. The patient has not exhibited any history of significant arrhythmias, such as sustained ventricular tachyarrhythmias or atrial fibrillation, which are common indications for pacemaker placement. Additionally, the absence of other complications like cardiac arrest or the need for emergency interventions suggests stable cardiac function after the Fontan procedure. These factors collectively indicate a low likelihood of requiring a pacemaker.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I would predict that the patient does not have a history of ascites (no). The absence of significant complications post-Fontan surgery and the lack of associated symptoms such as pleural effusions or elevated liver fibrosis indicators suggest that the patient's overall clinical status is stable. Additionally, the patient does not display any signs of protein-losing enteropathy, which is often associated with fluid retention issues. Therefore, the patient's MRI findings and surgical history indicate a lower likelihood of developing ascites.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, I would predict that the patient **did not receive a heart transplant**. The patient's status indicates no serious complications such as major thrombus, stroke, or significant arrhythmias, all of which are factors that could lead to worse clinical scenarios necessitating transplant. Additionally, the absence of ongoing issues like protein-losing enteropathy, atrial tachyarrhythmias, or renal dysfunction, aligns with a more stable condition post-Fontan surgery. Combined with the fact that the patient is currently categorized as NYHA class (which suggests they are managing reasonably well), it is likely that a heart transplant was not deemed necessary at this time.",1,0
BCH-TRATRI-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the patient's data, I would predict that the patient has not died (no). The absence of significant complications commonly associated with single-ventricle physiology post-Fontan surgery, such as thrombus, stroke, or pleural effusions, suggests a relatively stable clinical condition. Furthermore, the patient is currently in New York Heart Association (NYHA) class status and is on anticoagulant therapy, indicating ongoing management without severe deterioration. The lack of any chronic complications offers a positive outlook regarding survival.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the information provided, I predict that the patient does **not** have a history of pacemaker placement (no). The reasoning for this prediction is primarily based on the documented history of sinus node dysfunction, which is a common indication for pacemaker placement in patients with arrhythmias. However, the patient does not have any significant history of sustained ventricular arrhythmias or the need for a defibrillator, which often coincide with pacemaker placement. Additionally, their current management includes anticoagulants and pulmonary vasodilators but does not mention ongoing issues that would typically necessitate a pacemaker, suggesting that their cardiac management has been appropriately tailored without the need for pacing support.",0,1
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, I predict that the patient is alive (no for the outcome ""Has the patient died?""). The patient has experienced an emergent cardioversion and has a history of atrial tachyarrhythmias, which suggests that there have been significant cardiac challenges. However, the absence of critical conditions, such as protein-losing enteropathy, significant strokes, or major thrombus events, along with the maintenance of some cardiac function (as indicated by the documented NYHA class), supports a relatively stable status. Additionally, the patient's ongoing management with anticoagulants and pulmonary vasodilators suggests active clinical care, which is often indicative of a focus on preserving life in high-risk patients.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I predict that the patient does **not** have a history of ascites (> trace). This conclusion is supported by the absence of significant clinical markers that typically correlate with fluid retention, such as the lack of history of chylous pleural effusions lasting more than 30 days after surgery, renal dysfunction, or marked cardiovascular instability that could lead to fluid accumulation. Additionally, the patient's cardiac status indicates a high degree of management of arrhythmias through interventions like a pacemaker and an electrophysiologic study, which suggests that he has not encountered severe heart failure symptoms that would typically manifest as ascites in post-Fontan patients.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, I would predict that the patient did not receive a heart transplant (no). The patient has a history of emergent cardioversion and atrial tachyarrhythmias, both of which can indicate significant cardiac issues. However, there is no indication of severe end-stage heart failure, such as a history of sustained ventricular tachyarrhythmias, pulmonary hypertension requiring more drastic interventions, or other markers that typically lead to transplantation. Furthermore, the absence of evidence suggesting advanced cardiac dysfunction, such as renal impairment tied to heart failure or persistent pleural effusions, supports the conclusion that the patient may not be at the state requiring transplantation at this time.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the information provided, I would predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient has a history of arrhythmias, including emergent cardioversion and atrial tachyarrhythmias, but there is no mention of seizure episodes or neurological complications such as transient ischemic attacks or strokes that could contribute to seizure activity. Additionally, the absence of psychiatric medication use suggests that there may not be any underlying neurological issues requiring treatment. Therefore, given the lack of evidence for seizure-related symptoms in the provided history, it is reasonable to conclude that the patient is not diagnosed with seizures requiring treatment.",1,0
BCH-WEIALE-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, I predict that the missing clinical outcome is **no, the patient has not died**. The patient has a history of sinus node dysfunction and has undergone pacemaker placement, which suggests that their cardiac function is being managed. Additionally, there are no indications of life-threatening complications such as stroke, major thrombus, or significant liver dysfunction, and they are actively receiving medical management with anticoagulants, beta-blockers, and diuretics, all of which likely help to maintain their stability. Moreover, the patient’s current NYHA class status and lack of any escalating clinical problems provide further support for a favorable outcome in terms of survival.",1,0
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided information, it is predicted that the patient does not have a history of pacemaker placement. The patient's current status indicates sinus node dysfunction, which can sometimes necessitate the implantation of a pacemaker; however, there are no other alarming signs, such as significant arrhythmias or a history of cardiac arrest, that typically warrant such an intervention. Furthermore, the absence of documented interventions or elective procedures related to rhythm management suggests that the sinus node dysfunction has not reached a severity that necessitated a pacemaker thus far. Lastly, the patient's current medication regimen, which includes beta blockers but not other known treatments typically associated with pacemaker management, supports the likelihood of no previous pacemaker placement.",0,1
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? yes\n'],"Based on the provided information, I would predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). Despite the patient's complex surgical history and ongoing management with medications such as diuretics and beta blockers, there is no documented history of stroke or transient ischemic attack, which could be indicators of neurological issues such as seizures. Additionally, the patient's history shows a sinus node dysfunction, but not other significant neurological symptoms or a requirement for interventions commonly associated with seizure management, suggesting that seizures are unlikely. The absence of any critical findings related to seizures or the need for antiepileptic medications further supports this conclusion.",0,1
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the information provided, I would predict that the patient does **not** have a history of ascites (> trace). While the patient does have a history of non-chylous pleural effusions greater than 30 days after surgery, this does not directly correlate with ascites, which is a different condition often related to hepatic or vascular complications. Additionally, the patient has no history of significant liver pathology (e.g., no positive fibrosure, elevated liver fibrosis tests, or hepatocellular carcinoma) that could lead to fluid accumulations such as ascites. Furthermore, considering the absence of renal dysfunction and other complications, it is reasonable to conclude that ascites is unlikely to be present for this patient.",1,0
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? yes
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
",,Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data, I predict that the patient did **not** receive a heart transplant. Despite the patient's history of sinus node dysfunction and subsequent pacemaker placement, there is no indication of deteriorating cardiac function or significant complications that typically lead to a heart transplant. Specifically, the absence of major cardiac arrhythmias, the lack of renal dysfunction or hepatocellular complications, and the current NYHA class being classified as stable suggest that the patient's cardiac status is being managed effectively. Additionally, the fact that the patient is on anticoagulants, diuretics, and beta blockers without evidence of end-stage heart failure further supports the likelihood that transplantation was not necessary.",1,0
